SEC Filings

Filing date Form Description View
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

View HTML
S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

View HTML
S-1

Registration statement for face-amount certificate companies

View HTML
S-1

Registration statement for face-amount certificate companies

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb